The presence of heparanase in the nucleus leads to loss of the heparan sulfate proteoglycan syndecan-1 from the nucleus, resulting in enhanced histone acetyltransferase (HAT) activity and upregulation of expression of VEGF and MMP9, two genes that contribute to an aggressive tumor phenotype [6,7]. Here, SDC1 is linked to neoplasm.